OJOG  Vol.1 No.4 , December 2011
Amniotic fluid embolism: literature review and an integrated concept of pathomechanism
Literature concerning procoagulant activity of the amniotic fluid and pathomechanism of amniotic fluid embolism (AFE) was surveyed and a new concept of its pathogenesis, called the integrated concept of AFE, was presented. According to this concept, two components of the amniotic fluid are involved: (i) apoptosis-affected amniotic cells showing a special role in the initiation of disseminated intravascular coagulation (DIC) and (ii) leukotrienes (formerly called slow-reacting substances), inducing bronchial and pulmonary vascular smooth muscle contraction. Although each of these components initiates a different pathogenic pathway, they both lead to the formation of a mechanical barrier on blood flow through the lungs (amniotic debris + microemboli) and/or functional barrier (pulmonary vasoconstriction). An old dilemma, concerning indications for heparin therapy in AFE was recalled in the light of the new concept.

Cite this paper
nullUszyński, M. (2011) Amniotic fluid embolism: literature review and an integrated concept of pathomechanism. Open Journal of Obstetrics and Gynecology, 1, 178-183. doi: 10.4236/ojog.2011.14034.
[1]   Abenhaim, H.A., Azoulay, L., Kramer, M.S. and Leduc, L. (2008) Incidence and risk factors of amniotic fluid embolismus: A population-based study on 3 million births in the United States. American Journal of Obstetrics and Gynecology, 199, E1-E8. doi:10.1016/j.ajog.2007.11.061

[2]   Clark, S.L, Hankins, G.D.V., Dudley, D.A. and Dildy, G.A. (1995) Amniotic fluid embolism: Analysis of the national registry. American Journal of Obstetrics and Gynecology, 172, 1158-1169. doi:10.1016/0002-9378(95)91474-9

[3]   Steiner, P.E. and Lushbaugh, C.C. (1941) Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. Journal of the American Medical Association, 117, 1245-1254.

[4]   Meyer, J.R. (1992) Embolia pulmonary amnio caseosa. Clinics in Chest Medicine, 13, 657-665.

[5]   McDougall, R.J. and Duke, G.J. (1995) Amniotic fluid embolism syndrome: Case report and review. Anaesthesia and Intensive Care, 23, 735-740.

[6]   Bastien, J.L., Graves, J.R. and Bailey, S. (1998) Atypical presentation of amniotic fluid embolism. Anesthesia and Analgesia, 87, 124-126. doi:10.1097/00000539-199807000-00027

[7]   Fletcher, S.J. and Parr, M.J.A. (2000) Amniotic fluid embolism: A case report and review. Resuscitation, 43, 141-146. doi:10.1016/S0300-9572(99)00140-9

[8]   Awad, I.T. and Shorten, G.D. (2001) Amniotic fluid embolism and isolated coagulopathy: Atypical presentation of amniotic fluid embolism. European Journal of Anasthesiology, 18, 410-413. doi:10.1097/00003643-200106000-00011

[9]   Weiner, A.E., Reid, D.E. and Roby, C.C. (1949) Hemostatic activity of amniotic fluid. Science, 110, 190. doi:10.1126/science.110.2851.190

[10]   Clark, S.L. (1985) Arachidonic acid metabolites and the pathophysiology of amniotic fluid embolism. Seminars in Reproductive Endocrinology, 3, 253-257. doi:10.1055/s-2007-1022623

[11]   Azegami, M. and Mori, N. (1986) Amniotic fluid embolism and leukotriens. American Journal of Obstetrics and Gynecology, 155, 1119-1124.

[12]   Clark, S.L. (1990) New concept of amniotic fluid embolism: A review. Obstetrical and gynecological survey, 45, 360-368. doi:10.1097/00006254-199006000-00003

[13]   el-Maradny, E., Kanayama, N., Halim, A., Maehara, K. and Taro, T. (1995) Endothelin has a role in the early pathogenesis of amniotic fluid embolism. Gynecologic and Obstetric Investigation, 40, 14-18. doi:10.1159/000292294

[14]   Khong, T. (1998) Expression of endothelin-1 in amniotic fluid embolism and possible pathophysiological mechanism. British Journal of Obstetrics and Gynaecology, 105, 802-804. doi:10.1111/j.1471-0528.1998.tb10214.x

[15]   Robillard, J., Gauvin, F., Molinaro, G., Leduc, L., Adam, A. and Rivard, G.E. (2005) The syndrome of amniotic fluid embolism: A potential contribution of bradykinin. American Journal of Obstetrics and Gynecology, 193, 1508-1512. doi:10.1016/j.ajog.2005.03.022

[16]   Mutoh, S., The, A., Sato, M., Aoki, N., Ohno, Y. and Itoh, N. (1989) Studies on coagulation-fibrinolysis and Kallikrein-kinin systems and kininase activity and kininase II quantity in amniotic fluid. Advances in Experimental Medicine and Biology, 247, B559-567.

[17]   Zhou, J., Liu, S., Ma, M., Hou, J., Yu, H., Lu, Ch., Gilbert, G. and Jialan, S. (2009) Procoagulant activity and phosphatidylserine of amniotic fluid cells. Thrombosis and Haemostasis, 101, 845-851.

[18]   Brace, R.A. (1999) Physiology of amniotic fluid volume regulation. In: Amniotic fluid. Rao, K.A. and Ross, M.G., Eds., Prism Books Pvt Ltd. Bangalore, S110-132.

[19]   Tyden, O., Bergstrom, S. and Nilsson, B.A. (1980) Origin of amniotic fluid cells in mid-trimester pregnancies. British Journal of Obstetrics and Gynaecology, 88, 278-286.

[20]   Lockwood, C.J., Bach, R., Guha, A., Zhou, X., Miller, W.A. and Nemerson, Y. (1991) Amniotic fluid contains tissue factor, a potent initiator of coagulation. American Journal of Obstetrics and Gynecology, 165, 1335-1341.

[21]   Uszyński, M. and Uszyński, W. (2011) Coagulation and fibrinolysis in amniotic fluid: Physiology and observations on amniotic fluid embolism, preterm fetal membrane rupture, and pre-eclampsia. American Journal of Obstetrics and Gynecology, 37, 165-174.

[22]   Uszyński, M. (1999) Fibrinolytic system in amniotic fluid and foetal membranes. In: Amniotic fluid. Rao, A. and Ross, M.G. (red.) Prism Books Pvt Ltd. Bangalore, 163-175.

[23]   Slunsky, R. (1971) Klinik der Fruchtwasserembolie. Karger, Basel.

[24]   Hoffman, M. and Monroe III, D.M. (2001) A cell-based model of hemostasis. Thrombosis and Haemostasis, 85, 958-965.

[25]   Schneider, ChL. (1957) Fibrination and defibrination. In: Physiologie und pathologie der blutgerinnung in der gestationsperiode. Schattauer-Verlag, Stuttgart, 15-17.

[26]   Phillips, L.L. and Davidson, E.C. (1972) Procoagulant properties of amniotic fluid. American Journal of Obstetrics and Gynecology, 113, 911-919.

[27]   MacMillan, D. (1968) Experimental amniotic fluid infusion. Journal of obstetrics and gynaecology of the British Commonwealth, 75, 849-852. doi:10.1111/j.1471-0528.1968.tb01604.x

[28]   Uszyński, M., Zekanowska, E., Uszyński, W. and Kuczyński, J. (2001) Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: Implications for the mechanism of amniotic fluid embolism. European Journal of Obstetrics and Gynecology and Reproductive Biology, 95, 163-166. doi:10.1016/S0301-2115(00)00448-6

[29]   Esposito, R.A., Grossi, E.A., Coppa, G., Gianola, G., Ferri, D.P., Angelides, E.M. and Andriakos, P. (1990) Succesful treatment of shock caused by amniotic fluid embolism with cardiopulmonary bypass and pulmonary artery thromboembolectomy. American Journal of Obstetrics and Gynecology, 163, 572-574.

[30]   Stanten, R.D., Iverson, I.G., Daugharty, T.M., Lovett, S.M., Terrt, C. and Blumenstock, E. (2003) Amniotic fluid embolism causing catastrophic pulmonary vasoconstriction: Diagnosis by echocardiogram and treatment by cardiopulmonary bypass. Obstetrics Gynecology, 102, 496-498. doi:10.1016/S0029-7844(03)00161-3

[31]   Uszyński, M. (2009) Amniotic fluid embolism: The complication of known pathomechanism but without pathogenetic therapy? Thrombosis and Haemostasis, 101, 795-796.